Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Dabrafenib
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dabrafenib 50mg capsules
0801050CUAAAAAA
|
Dabrafenib | Dabrafenib | Malignant Disease and Immunosuppression | No data available |
|
Dabrafenib 75mg capsules
0801050CUAAABAB
|
Dabrafenib | Dabrafenib | Malignant Disease and Immunosuppression | No data available |
|
Tafinlar 50mg capsules
0801050CUBBAAAA
|
Tafinlar | Dabrafenib | Malignant Disease and Immunosuppression | No data available |
|
Tafinlar 75mg capsules
0801050CUBBABAB
|
Tafinlar | Dabrafenib | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.